Acerus Pharmaceuticals (TSX:ASP) Accounts Payable & Accrued Expense : C$16.50 Mil (As of Sep. 2022)

View and export this data going back to 2009. Start your Free Trial

What is Acerus Pharmaceuticals Accounts Payable & Accrued Expense?

Acerus Pharmaceuticals's quarterly accounts payable & accrued expense increased from Mar. 2022 (C$16.76 Mil) to Jun. 2022 (C$17.74 Mil) but then declined from Jun. 2022 (C$17.74 Mil) to Sep. 2022 (C$16.50 Mil).

Acerus Pharmaceuticals's annual accounts payable & accrued expense declined from Dec. 2019 (C$8.53 Mil) to Dec. 2020 (C$6.50 Mil) but then increased from Dec. 2020 (C$6.50 Mil) to Dec. 2021 (C$12.66 Mil).

Acerus Pharmaceuticals Accounts Payable & Accrued Expense Historical Data

The historical data trend for Acerus Pharmaceuticals's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acerus Pharmaceuticals Accounts Payable & Accrued Expense Chart

Acerus Pharmaceuticals Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

3.86

7.27

8.53

6.50

12.66

Acerus Pharmaceuticals Quarterly Data
	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															12.54	12.66	16.76	17.74	16.50

Acerus Pharmaceuticals Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Acerus Pharmaceuticals (TSX:ASP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Acerus Pharmaceuticals Corp (TSX:ASP) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

7025 Langer Drive, Suite 205, Mississauga, ON, CAN, L5N 0E8

Website

https://www.aceruspharma.com

Acerus Pharmaceuticals Corp is a specialty pharmaceutical company focused on the development, manufacture, marketing and distribution of branded products that improve patient experience, with a primary focus on the field of men's health. Its foundational product includes NATESTO, a testosterone therapy based on nasal gel technology. The company commercializes its products via its salesforce in the United States and Canada, and through a global network of licensed distributors in other territories.

Executives

Norma Beauchamp	Director
Stephen Robert Gregory	Director
Edward Joseph Gudaitis	Director, Senior Officer